Shares of Vertex Pharmaceuticals Inc. VRTX shed 4.07% to $448.01 Tuesday, on what proved to be an all-around mixed trading ...

A Relative Strength Rating upgrade for Vertex Pharmaceuticals shows improving technical performance. Will it continue?

Vertex Pharmaceuticals beat Wall Street's third-quarter expectations, but the real story for Vertex stock is still to come, analysts said Tuesday.Please watch the video at Investors.com - How To Buy ...

Vertex (VERX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. Research reveals gaps and challenges to optimize tax ...

The headline numbers for Vertex (VRTX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Vertex Pharmaceuticals has a virtual monopoly in treating cystic fibrosis, having created and brought to market a function cure for 90% of the CF population. Their pipeline outside of CF has shown ...

KING OF PRUSSIA, Pa. (AP) — KING OF PRUSSIA, Pa. (AP) — Vertex, Inc. (VERX) on Wednesday reported third-quarter profit of $7.2 million. On a per-share basis, the King Of Prussia, Pennsylvania-based ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Vertex Energy ( (VTNRQ)) just unveiled an announcement. Vertex Energy, Inc. announced a retention bonus agreement with their newly appointed Chief Commercial Officer, Joshua Foster, aimed at ...

Vertex Pharmaceuticals is in the process of getting a new painkiller approved. It just published some data that suggests the candidate will be quite profitable. But regulators still need to sign ...